Lorlatinib API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Lorlatinib API is an active pharmaceutical ingredient belonging to the tyrosine kinase inhibitor class of antineoplastic compounds. It is a small-molecule kinase inhibitor associated with targeted oncology pharmaceutical formulations.

Lorlatinib inhibits anaplastic lymphoma kinase (ALK) and ROS1 tyrosine kinases. Inhibition of these kinase pathways interferes with signaling mechanisms associated with the growth and survival of certain cancer cells.

Lorlatinib is associated with pharmaceutical formulations used for ALK-positive metastatic non-small cell lung cancer under applicable medical and regulatory requirements.

Swapnroop Drugs & Pharmaceuticals supplies Lorlatinib API for pharmaceutical formulation development, oncology research, analytical studies, and commercial manufacturing requirements. We focus on consistent product quality, reliable pharmaceutical sourcing, secure packaging, technical documentation, and dependable bulk supply services.

Lorlatinib API can be supplied with batch-specific Certificate of Analysis (COA) and available technical documentation according to customer requirements. Product specifications, purity parameters, chiral purity, particle size, packaging, and commercial quantities can be discussed based on individual pharmaceutical sourcing requirements.

Applications

Lorlatinib API is primarily used in the pharmaceutical and oncology sectors for the development and manufacture of targeted antineoplastic pharmaceutical formulations.

It is used in:

Oncology pharmaceutical formulations
ALK inhibitor pharmaceutical products
ROS1 inhibitor research and development
Tyrosine kinase inhibitor formulations
Non-small cell lung cancer pharmaceutical development
Oral solid dosage formulation development
Tablet formulation development
Pharmaceutical research and development
Analytical and formulation studies
Commercial pharmaceutical manufacturing

All applications are subject to applicable pharmaceutical regulations, approved formulations, intellectual property requirements, and regulatory approvals.

Packaging

Lorlatinib API is supplied in suitable pharmaceutical-grade packaging designed to protect the material from light, moisture, and contamination.

Packaging may include suitable pharmaceutical-grade inner liners and securely sealed outer containers according to product characteristics and customer requirements.

Customized bulk packaging quantities may be available based on commercial and pharmaceutical manufacturing requirements.

Why Choose Swapnroop Drugs & Pharmaceuticals?

Swapnroop Drugs & Pharmaceuticals is a pharmaceutical raw material and API supplier based in Maharashtra, India. We provide pharmaceutical ingredients to domestic and international customers with a focus on consistent sourcing and reliable supply support.

Our key supply advantages include:

High-quality pharmaceutical raw materials
Specialized oncology API sourcing support
Batch-specific Certificate of Analysis
Technical documentation support
Secure pharmaceutical-grade packaging
Bulk quantity supply solutions
Export inquiry support
Reliable customer communication
Customized sourcing solutions

For Lorlatinib API bulk supply, technical specifications, COA requirements, commercial quotations, and export inquiries, contact Swapnroop Drugs & Pharmaceuticals.

Get Bulk Quote via WhatsApp